Hanspeter Gerber

Company: Codeable Therapeutics

Job title: Chief Scientific Officer & Co-Founder


Selecting Optimal Linker-Payload Technology to Complement Your Target 9:30 am

Choosing the optimal linker-payload technology in liquid tumors Delving into linker-payload selection in solid tumors Marrying ideal linker-payload and antibody to best complement your target and expand therapeutic windowsRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.